In a recent study published in the journal Circulation , researchers projected the economic burden of cardiovascular disease and stroke (CVDS) in the United States (U.S.) through 2050, using comprehensive health, economic, and demographic data to inform effective policy and health system interventions.
Study: Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association . Image Credit: Mr Dasenna / Shutterstock In 2022, U.S.
healthcare spending reached $4.2 trillion, a 62% increase from a decade earlier, accounting for 17% of Gross Domestic Product (GDP). Per-capita spending was $12,555, 2.
5 times higher than in other developed countries. CVDS contributed $251 billion in 2019, with an additional $156 billion in lost productivity. Rising obesity, diabetes, uncontrolled blood pressure, aging, and higher-risk demographic groups are expected to increase CVDS-related costs further.
Effective projections and further research are crucial for developing strategies to reduce healthcare costs and improve the prevention and treatment of CVDS. The study projected future cardiovascular costs by estimating baseline healthcare costs for individuals with cardiovascular risk factors or CVDS conditions by age and sex, using nationally representative survey data. Productivity losses from morbidity and premature mortality were also calculated.
These costs were projected through 2050, assuming an.
